The role of fine needle aspiration cytology in the management of gynecologic malignancies

A. T. Moriarty, M. D. Glant, Frederick Stehman

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Between 1978 and 1983, 317 diagnostic fine needle aspirations (FNA) were procured at Indiana University by the Cytology, Radiology or Gynecology services for initial evaluation or follow-up of proven gynecologic malignancies. The primary sites of the neoplasms included the cervix, uterus, ovary, vagina and vulva. Totals of 199 samples were procured from superficial sites, including parametrium, vagina, subcutaneous tissue and superficial lymph nodes, and 118 were obtained from deep soft tissues, abdominal organs, pelvis and deep lymph nodes. Of the FNA specimens, 146 (46%) were cytologically diagnosed as malignant and 171 (54%) were reported as benign. Of the specimens initially given negative diagnoses, 35 (11%) werre inadequate samples. No complications occurred as a result of FNA biopsy. All cases were reclassified using strict criteria for an inadequate specimen. After review, 79 biopsies were considered either scant (22%) or inappropriate (0.03%) for the target lesion. Scant specimens were obtained more often in superficial than in deep sites. No significant differences were found in the false-negative rate between superficial and deep sites; all false positives were from superficial sites. The use of strict criteria for adequacy of a sample (two groups of appropriate cells on two separate slides) yielded a specificity of 95%, an increased sensitivity from 73% to 91%, a predictive value for a positive result of 98% and a predictive value for a negative result of 84%. Use of strict criteria for specimen adequacy served to reemphasize two points regarding negative FNA results: (1) that rebiopsy should be suggested and (2) that on-site assessment of the specimen adequacy should be made during the aspiration.

Original languageEnglish
Pages (from-to)59-64
Number of pages6
JournalActa Cytologica
Volume30
Issue number1
StatePublished - 1986

Fingerprint

Fine Needle Biopsy
Cell Biology
Vagina
Neoplasms
Neoplasms by Site
Lymph Nodes
Vulva
Peritoneum
Subcutaneous Tissue
Pelvis
Gynecology
Radiology
Cervix Uteri
Ovary
Biopsy

ASJC Scopus subject areas

  • Cell Biology
  • Anatomy
  • Histology

Cite this

The role of fine needle aspiration cytology in the management of gynecologic malignancies. / Moriarty, A. T.; Glant, M. D.; Stehman, Frederick.

In: Acta Cytologica, Vol. 30, No. 1, 1986, p. 59-64.

Research output: Contribution to journalArticle

@article{977c7c915a8e4778af2aeb1f04eb6fb3,
title = "The role of fine needle aspiration cytology in the management of gynecologic malignancies",
abstract = "Between 1978 and 1983, 317 diagnostic fine needle aspirations (FNA) were procured at Indiana University by the Cytology, Radiology or Gynecology services for initial evaluation or follow-up of proven gynecologic malignancies. The primary sites of the neoplasms included the cervix, uterus, ovary, vagina and vulva. Totals of 199 samples were procured from superficial sites, including parametrium, vagina, subcutaneous tissue and superficial lymph nodes, and 118 were obtained from deep soft tissues, abdominal organs, pelvis and deep lymph nodes. Of the FNA specimens, 146 (46{\%}) were cytologically diagnosed as malignant and 171 (54{\%}) were reported as benign. Of the specimens initially given negative diagnoses, 35 (11{\%}) werre inadequate samples. No complications occurred as a result of FNA biopsy. All cases were reclassified using strict criteria for an inadequate specimen. After review, 79 biopsies were considered either scant (22{\%}) or inappropriate (0.03{\%}) for the target lesion. Scant specimens were obtained more often in superficial than in deep sites. No significant differences were found in the false-negative rate between superficial and deep sites; all false positives were from superficial sites. The use of strict criteria for adequacy of a sample (two groups of appropriate cells on two separate slides) yielded a specificity of 95{\%}, an increased sensitivity from 73{\%} to 91{\%}, a predictive value for a positive result of 98{\%} and a predictive value for a negative result of 84{\%}. Use of strict criteria for specimen adequacy served to reemphasize two points regarding negative FNA results: (1) that rebiopsy should be suggested and (2) that on-site assessment of the specimen adequacy should be made during the aspiration.",
author = "Moriarty, {A. T.} and Glant, {M. D.} and Frederick Stehman",
year = "1986",
language = "English",
volume = "30",
pages = "59--64",
journal = "Acta Cytologica",
issn = "0001-5547",
publisher = "Science Printers and Publishers Inc.",
number = "1",

}

TY - JOUR

T1 - The role of fine needle aspiration cytology in the management of gynecologic malignancies

AU - Moriarty, A. T.

AU - Glant, M. D.

AU - Stehman, Frederick

PY - 1986

Y1 - 1986

N2 - Between 1978 and 1983, 317 diagnostic fine needle aspirations (FNA) were procured at Indiana University by the Cytology, Radiology or Gynecology services for initial evaluation or follow-up of proven gynecologic malignancies. The primary sites of the neoplasms included the cervix, uterus, ovary, vagina and vulva. Totals of 199 samples were procured from superficial sites, including parametrium, vagina, subcutaneous tissue and superficial lymph nodes, and 118 were obtained from deep soft tissues, abdominal organs, pelvis and deep lymph nodes. Of the FNA specimens, 146 (46%) were cytologically diagnosed as malignant and 171 (54%) were reported as benign. Of the specimens initially given negative diagnoses, 35 (11%) werre inadequate samples. No complications occurred as a result of FNA biopsy. All cases were reclassified using strict criteria for an inadequate specimen. After review, 79 biopsies were considered either scant (22%) or inappropriate (0.03%) for the target lesion. Scant specimens were obtained more often in superficial than in deep sites. No significant differences were found in the false-negative rate between superficial and deep sites; all false positives were from superficial sites. The use of strict criteria for adequacy of a sample (two groups of appropriate cells on two separate slides) yielded a specificity of 95%, an increased sensitivity from 73% to 91%, a predictive value for a positive result of 98% and a predictive value for a negative result of 84%. Use of strict criteria for specimen adequacy served to reemphasize two points regarding negative FNA results: (1) that rebiopsy should be suggested and (2) that on-site assessment of the specimen adequacy should be made during the aspiration.

AB - Between 1978 and 1983, 317 diagnostic fine needle aspirations (FNA) were procured at Indiana University by the Cytology, Radiology or Gynecology services for initial evaluation or follow-up of proven gynecologic malignancies. The primary sites of the neoplasms included the cervix, uterus, ovary, vagina and vulva. Totals of 199 samples were procured from superficial sites, including parametrium, vagina, subcutaneous tissue and superficial lymph nodes, and 118 were obtained from deep soft tissues, abdominal organs, pelvis and deep lymph nodes. Of the FNA specimens, 146 (46%) were cytologically diagnosed as malignant and 171 (54%) were reported as benign. Of the specimens initially given negative diagnoses, 35 (11%) werre inadequate samples. No complications occurred as a result of FNA biopsy. All cases were reclassified using strict criteria for an inadequate specimen. After review, 79 biopsies were considered either scant (22%) or inappropriate (0.03%) for the target lesion. Scant specimens were obtained more often in superficial than in deep sites. No significant differences were found in the false-negative rate between superficial and deep sites; all false positives were from superficial sites. The use of strict criteria for adequacy of a sample (two groups of appropriate cells on two separate slides) yielded a specificity of 95%, an increased sensitivity from 73% to 91%, a predictive value for a positive result of 98% and a predictive value for a negative result of 84%. Use of strict criteria for specimen adequacy served to reemphasize two points regarding negative FNA results: (1) that rebiopsy should be suggested and (2) that on-site assessment of the specimen adequacy should be made during the aspiration.

UR - http://www.scopus.com/inward/record.url?scp=0022650699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022650699&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 59

EP - 64

JO - Acta Cytologica

JF - Acta Cytologica

SN - 0001-5547

IS - 1

ER -